What's breaking now, across thousands of outlets.
Despite what some analysts described as low expectations, RAP-219 narrowly hit the main goal of a mid-stage study, results that could help it tap a billion-dollar-plus market opportunity.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Leptospirosis can initially resemble common monsoon illnesses, but without timely diagnosis and treatment, it can progress to life-threatening complications affecting the kidneys, liver and lungs
Researchers developed a drug for Alzheimer's disease and then discovered that the molecule already exists in human blood and is found at lower levels in cognitively impaired people.
Your fitness tracker may reveal more than your daily step count. It could also offer clues about your future brain health.
A respected figure in the world of global health, Dr. Kerry takes on a new responsibility. She says it's challenging but not "daunting."
(MedPage Today) -- One-year results from the open-label extension of the phase III MINT trial presented at the American Association of Neuromuscular and Electrodiagnostic Medicine annual meeting…
The experts used 3D models to uncover how cancer cells responded when mechanically confined for prolonged periods of time.
